In the News
Catch up on the latest Omnicell and healthcare industry news
-
Who Could Drive Bipartisan Health Reforms in the U.S. Senate?
The potential for bipartisanship approaches to healthcare reform is examined in this article in Electronic Health Reporter authored by Ken Perez, Omnicell's VP of Healthcare Policy and Government Affairs.
-
Herd Immunity and the Prospect of Seeing an End to the COVID-19 Crisis
In this HFMA blog post, Ken Perez, Omnicell's VP of Healthcare Policy and Government Affairs, takes a close look at achieving herd immunity to COVID-19 in the U.S.
-
Why Omnicell's CEO Puts Progress Over Politics
Investor’s Business Daily featured Randall Lipps, Omnicell Chairman, President, CEO, and Founder, in their Leaders & Success series, which highlights innovative leaders who are changing their respective industries. The profile details Omnicell’s growth, the Autonomous Pharmacy vision, and Randall’s commitment to understanding customer problems through personal interactions.
-
The Top 50 Healthcare Technology CEOs of 2021
Randall Lipps, Omnicell Chairman, President, CEO, and Founder, was named #9 on the 2021 list of Top 50 Healthcare Technology CEOs as curated by Healthcare Technology Report. This prestigious award recognizes the most accomplished executives in healthcare technology.
-
What Cart, Workstation Improvements Would You Make?
In this Healthcare Purchasing News article, Omnicell's Director of Product Marketing for Point of Care Solutions discusses opportunities to harness data from Omnicell Autonomated Dispensing Systems.
-
The American Rescue Plan Act of 2021: What’s in it for Hospitals?
In this Electronic Health Reporter article, Omnicell VP of Healthcare Policy and Government Affairs, Ken Perez, looks at the provisions of this new act that either directly or indirectly benefit hospitals.
-
56% Rate of Adherence to Sterile Compounding SOPs Is ‘Crazy’
This article in Pharmacy Practice News highlights ISMP’s 2020 survey on IV accuracy, which revealed major gaps in best practice compliance.
-
The Fall of Haven, but the Persistence of Amazon
In this HFMA blog post, Omnicell's Ken Perez reflects on the closure of Haven, the healthcare company formed three years ago as a partnership between Amazon, Berkshire Hathaway, and JPMorgan Chase.
-
Allegheny Makes a Case for IV Robotics
This Pharmacy Practice News article features Allegheny General Hospital’s use of Omnicell robotic IV technology to eliminate error in the hospital’s IV compounding process and improve overall operations.
-
Tools of the Trade: How Tech, Automation Are Helping Pharmacies Manage the COVID Crunch
This Drug Store News article discusses how technology and automation are helping pharmacies manage the influx of demands caused by COVID-19. CareScheduler technology from our EnlivenHealth division is featured.
-
Scheduling Vendors Say a More Proactive Approach Is Needed for Vaccine Rollout
This Healthcare IT News coverage looks at scheduling tools to support the COVID-19 vaccine rollout. Danny Sanchez, Vice President and General Manager for Omnicell’s EnlivenHealth division, discusses how the CareScheduler solution can help.
-
'Bidencare': What's Achievable?
In this HFMA blog, Ken Perez, Omnicell's VP of Healthcare Policy, looks at the reality of implementing new health policy changes.
-
Vaccine Rollout: Americans Urged to 'Hang Tight' While Booking Appointments Online
In this ABC News coverage, Danny Sanchez, Vice President and General Manager for Omnicell’s EnlivenHealth division, discusses the promise of high tech solutions to aid in rolling out the COVD-19 vaccine.
-
Who’s Who in Pharmacy Automation and Technology
This article in Drug Store News features pharmacy technology companies, including Omnicell's EnlivenHealth, that are helping pharmacists juggle added responsibilities amid the pandemic.
-
The Prospects for Reining in Prescription Drug Costs Under a Biden Administration
In this Electronic Health Reporter article, Omnicell VP of Healthcare Policy, Ken Perez, discusses the outlook for controlling drug costs under the new administration.
-
The Challenges Pfizer Faces Distributing its Covid-19 Vaccine to the Masses
Danny Sanchez, VP and General Manager of Omnicell’s EnlivenHealth division comments on the role community pharmacies can play in distribution of the COVID-19 vaccine.
Previous